ArticleFrontiers in public health2025
Determinants of the lost to follow-up status among patients with tuberculosis who emigrated to the Republic of Korea: a mixed-method study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Overview of Tuberculosis Cases Reported in 2024 in the Capital Region: Seoul Metropolitan City, Incheon Metropolitan City, Gyeonggi-do, and Gangwon State.Jugan geon-gang gwa jilbyeong · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Tuberculosis (TB) remains a significant global health concern, with foreign migrants in the Republic of Korea (ROK) representing a particularly vulnerable group; despite comprising only 3.5% of the population, they account for over 5% of annual TB cases and exhibit disproportionately high rates of lost to follow up (LTFU) from treatment compared to native Koreans. This mixed-methods study aimed to identify key factors influencing non-adherence to treatment and LTFU among migrants. Methods: Utilizing national TB surveillance data from 2016 to 2018 for 4,011 migrant and 64,620 native patients, quantitative analysis were employed to identify factors associated with LTFU for migrants. Complementary in-depth qualitative interviews with Public-Private Mix (PPM) nurses provided deeper insights into barriers to adherence. Results: The study revealed a significantly higher LTFU rate (21.5%) among migrant patients compared to domestic patients (2.3%). Key contributing factors included nationality (highest crude odds for migrants from Thailand, Central, and North Asia), living arrangements (increased risk for those not with family or living alone), and male gender. Drug-resistant TB made patients over four times more likely to discontinue treatment and systemic issues such as frequent care transfers and the presence of comorbidities. Qualitative findings highlighted inadequate patient education and misconceptions about TB severity (often seen as a "mild cold"), leading to premature discontinuation. Poor medical interpretation services and low awareness among migrants of free TB treatment under the PPM program were also critical barriers. Discussion: These findings imply that high LTFU among migrant patients is multifactorial, stemming from personal, clinical, and systemic issues. Addressing this disparity requires targeted interventions, including culturally tailored multilingual educational campaigns, improved medical interpretation, and increased awareness of PPM program eligibility and free treatment. Streamlining interfacility care transfer processes (such as the "Tuberculosis Relief Belt" initiative), expanding PPM coverage, and ensuring access to specialized care for comorbid conditions are also essential. Addressing these multifaceted challenges is critical to reducing LTFU rates and enhancing treatment continuity and outcomes, thereby advancing TB control efforts in ROK's shifting migration context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.